Journal of Endocrinology
/publications/journal-items/journal-of-endocrinology/
Journal of Endocrinology is the Society's flagship journal that publishes original research articles, reviews and science guidelines. Its focus is on endocrine physiology and metabolism, including hormone secretion; hormone action; biological effects. The journal publishes basic and translational studies at the organ, tissue and whole organism level. Alongside the core endocrinology topics, the journal also encourages submissions on cardiovascular, muscle and renal endocrinology as well as submissions on the immune system where this impacts the endocrine system
Professor Richard Anderson
/events/reproductive-endocrinology/reproductive-endocrinology-2025/founding-group/group-members/professor-richard-anderson/
Richard Anderson is Elsie Inglis Professor of Clinical Reproductive Science at the University of Edinburgh Centre for Reproductive Health and works clinically in Infertility and Reproductive Endocrinology. He has interests in both female and male fertility, including hormonal male contraception, fertility preservation and the effects of cancer treatments on fertility, and he has also conducted clinical studies developing our understanding of novel neuropeptides in human reproductive function in men and women. He is a member of the HFEA Scientific and Clinical Advances Advisory Committee and the NICHD Scientific Consulting Group of the Contraception Discovery and Development Branch, and until recently, was a member of the ESHRE Executive Committee.
Aaron Novikoff
/events/endocrine-metabolic-gpcrs/endocrine-metabolic-gpcrs-2026/founding-group/group-members/aaron-novikoff/
Aaron Novikoff is a tenured postdoctoral researcher at Helmholtz Munich – Institute for Diabetes and Obesity. He earned his PhD in 2022 at Helmholtz Munich, where he investigated the molecular pharmacology of novel incretin receptor dual- and triple-agonists, as well as nuclear hormone-conjugated GLP-1 agonists, under the mentorship of Prof. Timo Müller and Prof. Matthias Tschöp. As a Helmholtz High Potential Fellow, his current research centers on novel peptide-based drug design, with an emphasis on harnessing subcellular dynamics and polypharmacology to enhance systemic therapeutic outcomes against diabetes and obesity.